BREAKING NEWS: Prof Todd Davenport & CPTJ Dedicated to Long COVID Rehabilitation
Breaking News Prof Todd Davenport Edits the January edition of CPTJ Dedicated to Long COVID Rehabilitation
Breaking News Prof Todd Davenport Edits the January edition of CPTJ Dedicated to Long COVID Rehabilitation
PROFESSOR KLIMAS HAS FDA APPROVAL FOR MONOCLONAL ANTIBODY RESEARCH!
E27: Dr. David Putrino discusses the hormonal and neurological impacts of Long COVID, highlighting key research findings, symptom patterns, and emerging treatments through innovative therapies and clinical trials.
E26: Explore cutting-edge research on Long COVID and ME/CFS with Dr. Nancy Klimas, uncovering innovative treatments, immune system insights, and the transformative potential of holistic healthcare approaches.
E25: Explore Mast Cell Activation Syndrome (MCAS) with Dr. Funmi Okunola and Dr. David L. Kaufman. Uncover diagnostic challenges, innovative treatments, and expert insights to transform patient care. Tune in now!
E23 In this episode, the Post COVID Long-term Recovery Collaborative (PLRC) members Lisa McCorkell, Gina Assaf, and LetÃcia Soares discuss their work supporting long COVID patients and advocating for better healthcare responses.
PROFESSOR KLIMAS HAS FDA APPROVAL FOR MONOCLONAL ANTIBODY RESEARCH!
E23 Join Prof Nancy Klimas to discover groundbreaking insights into Long COVID treatments! Explore how monoclonal antibodies offer hope by targeting viral persistence and spike proteins. Learn from leading experts shaping the future of recovery and resilience.
An evidence-based 4-part pilot series tackles often-overlooked aspects like neuroinflammation and nervous system dysregulation to make you feel like yourself again! Register now!
Damage to the ANS leads to the following symptoms - palpitations, fainting, nausea, brain fog, headaches, fatigue, chest pain, dizziness, gastrointestinal disturbances as a direct result of the organs affected.